Duration of anticoagulation following venous thromboembolism: a meta-analysis.
about
Diagnosis and treatment of deep-vein thrombosisRecurrent venous thromboembolism: what is the risk and how to prevent itDiagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice GuidelinesGuidelines on oral anticoagulation with warfarin - fourth editionUnusual presentation of a massive pulmonary embolism.Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsBleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.Optimal duration of anticoagulation after venous thromboembolism.Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis.The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patientsCurrent and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran.Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant managementControversies in the antiphospholipid syndrome: can we ever stop warfarin?Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecologyScreening for coagulation disorders in patients with ischemic stroke.An approach to the patient with retiform purpura.The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children.Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.Optimal treatment duration of venous thrombosis.Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital.How to effectively manage the event of bleeding complications when using anticoagulants.Managing Extended Oral Anticoagulation After Unprovoked Venous Thromboembolism.Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention.Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy.
P2860
Q24673847-0B9F76E2-FBD9-4852-A570-251A7DF5B422Q26826847-DAE704D8-2EDE-4214-9C9E-3908D7FD2740Q28072833-8E6C1C4D-42DA-4D4F-B93A-DDD868A5E726Q28240666-59658B3D-4679-438C-9FE4-CBF7F0FD32CAQ33161905-02D7DED5-5D60-42F2-AFDE-8CC13D2C027FQ33637113-BDCDBC0A-C9F7-4D84-B064-11CCE42159B5Q33910755-81CE8CCD-0FED-4601-AF69-AA90F33230D1Q34132273-D39E2A6E-09A3-404E-91F5-79EE9C30EFE3Q34781477-829113D8-898E-4C67-A0D3-F245133BA767Q35536251-7D9ACC8E-09DF-4F75-899C-E58CA9AA4A5DQ35683034-B9D3F9EA-BCC8-4F5B-B0D7-2662411050D0Q35683869-94CF0908-DE60-4EA7-98FA-8C7DBD930DCAQ35724847-46A35C9F-48A9-4B8E-965B-934077F5C3D0Q36561057-9495B1A7-2A89-4880-9EF9-A58941DAF010Q37076800-EECD8265-173A-48CF-84AE-42D4F63AFC45Q37611378-EB628706-DE90-47D0-A2C9-7CE7B1E90BF6Q37775992-5075890F-ABCB-4C77-8535-B36F791EE324Q37853593-3FD7B173-0B15-4C80-908D-849F0A52D2A9Q37959385-5B9FA4CA-EF99-4BFC-BF14-5628A4B11E42Q38049617-23B941AC-D414-4DC9-9AC8-233E58F16EA8Q38117732-ED227C31-993C-422B-A01A-DF08D809F125Q38163400-AF883D81-007A-4F91-A826-FBA6329F01B2Q38634835-3915BFD5-21E3-4448-A7BB-983AF16DBDA1Q38850540-34E08FA8-17AA-454D-B7F3-E1F075B4D853Q39971724-9E1FE5A1-7B02-4E3A-8ACD-18B219E8B208Q41118456-AEDAD1DE-F873-486C-86F1-366BA88A78A8Q45119524-B258D4D6-179E-49E0-9A27-AB1F9793672EQ51136199-D8720947-3C8D-4EE0-A123-C72007267AC1
P2860
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@ast
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@en
type
label
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@ast
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@en
prefLabel
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@ast
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@en
P2093
P356
P1476
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
@en
P2093
Hanako Mihara
Josh Tepper
Owen Lander
Raphael Heinzer
P304
P356
10.1001/JAMA.294.6.706
P407
P50
P577
2005-08-01T00:00:00Z